Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Por um escritor misterioso
Descrição
SGEM Xtra: The NNT is Mellow Yellow for tPA in Acute Ischemic Stroke - The Skeptics Guide to Emergency Medicine
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Diagnosis and management of acute ischaemic stroke
Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke
Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I
Sonosensitive capsules for brain thrombolysis increase ischemic damage in a stroke model, Journal of Nanobiotechnology
Thrombus composition and thrombolysis resistance in stroke - Research and Practice in Thrombosis and Haemostasis
Biomedicines, Free Full-Text
Thrombolysis in Stroke Mimics Is Not Harmless - ACEP Now
IJERPH, Free Full-Text
– Emergency Medicine EducationThrombolytic Use for STEMI: What ED Clinicians Should Know - - Emergency Medicine Education
tPA Mobilizes Immune Cells That Exacerbate Hemorrhagic Transformation in Stroke
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Acute Ischemic Stroke and Long-Term Outcome After Thrombolysis
Trends in acute ischemic stroke treatments and mortality in the United States from 2012 to 2018 in: Neurosurgical Focus Volume 51 Issue 1 (2021) Journals
de
por adulto (o preço varia de acordo com o tamanho do grupo)
